[ET Net News Agency, 22 May 2019] China Traditional Chinese Medicine Holdings Co.
Limited (00570) said its controlling shareholder, China National Pharmaceutical Group
Corporation (CNPGC), has acquired 5 million shares of the company on the market through
its wholly-owned subsidiary, Sinopharm Group Hongkong Co. Limited (Sinopharm Hongkong) on
21 May 2019. The average price of the increase in shareholding is approximately HK$4.08
per share.
CNPGC through Sinopharm Hongkong indirectly now holds 1.62 billion shares of the
company, representing approximately 32.16% of the total issued share capital of the
Company.
Based on the confidence of sustainable growth of the company, CNPGC plans to further
increase its shareholding in the company by acquiring in aggregate no more than 50 million
shares of the company through Sinopharm Hongkong during the six-month period commencing
from 21 May 2019 with its own funds. (RC)